PurpleAI Logo
Solutions▼
Hyper Insight™
ICHICH PlusInfarctASPECTSCTA AneurysmCTA 3DCTPDWI InfarctCTA Infarct (LVO)MRA AneurysmStrokeShieldAI™
Research
Company▼
AboutLeadershipPartners
News & Insights
Brochure▼
All Solutions Overview
Full Hyper Insight™ solution lineup

All articles

  • Meet PurpleAI at KEMA 2026
  • Meet PurpleAI at KSIN 2026
  • Day 3 at AOCR & SGCR-WIRES 2026, our busiest yet.
  • Day 2 at AOCR & SGCR-WIRES 2026, Singapore EXPO.
  • Setup day at AOCR 2026, Singapore EXPO.
  • Meet Yoonmin Lee at CARPL's booth #D3— AOCR & SGCR-WIRES 2026, Singapore EXPO, 20–23 August.
  • PurpleAI will be at AOCR SGCR-WIRES 2026 in Singapore, 20–23 August
  • Impact of a computed tomography-based artificial intelligence software on radiologists’ workflow for detecting acute intracranial hemorrhage
  • Real-world multimetric comparison of four commercial AI solutions for intracranial hemorrhage detection
  • PurpleAI and Savelife.AI Go Live with FDA Cleared AI Stroke Triage at White Rock Medical Center
  • PurpleAI exhibiting at PPTC 2026 (Busan)
  • Purple AI exhibiting at ASCENT 2026 (KoNES)
  • 퍼플에이아이 뇌경색 진단 AI 임상 논문, 국제학술지 게재
  • Research co-authored by CTO Hoon Na published in Scientific Reports
  • PurpleAI named to BDMT Global Top 40 Global Innovations
  • PurpleAI heading to KSIN 2026
  • PurpleAI at 2026 KSEM Spring Congress
  • Meet PurpleAI at KSNR 2026 (Changwon)
  • Medical Insight supporting stroke care at Hallym University Hospital
  • PurpleAI announces advisory engagement with Joshua Goldstein, MD, PhD
  • Happy Lunar New Year
  • ISC 2026 New Orleans recap
  • PurpleAI attending ISC 2026
  • Wishing You a Bright & Innovative New Year
  • Our New Website Has Launched
  • RSNA 2025 - Day 4
  • RSNA 2025 - Day 3
  • RSNA 2025 - Day 2
  • RSNA 2025 - Day 1
  • PurpleAI at KoNES 2025 (Seoul)
  • PurpleAI Achieves ISO 13485 & ISO/IEC 27001 Certification
  • AI Showcase Theater presentation at RSNA 2025
  • PurpleAI at RSNA 2025 (Chicago)
  • PurpleAI at KSEM 2025 (Seoul)
  • PurpleAI Featured in National Media
  • PurpleAI at KoSAIM 2025
  • Day 3 at KCR 2025
  • Day 2 at KCR 2025
  • PurpleAI at MICCAI 2025 (panel recap)
  • Day 1 at KCR 2025
  • Ajou University Medical Center Research Hospital Symposium
  • Welcoming the CARPL team to Seoul office
  • PurpleAI at KCR 2025 (announcement)
  • KHF 2025 exhibition announcement
  • PurpleAI at MICCAI 2025 (announcement)
  • PurpleAI at KoNES-KSCVS 2025
  • Happy Labor Day
  • PurpleAI at KSIN 2025
  • 1st Neurosurgical Digital Convergence Symposium
  • PurpleAI at ASCENT 2025
  • PurpleAI Achieves ISO 13485 Certification
  • AI Aneurysm module receives KFDA clearance
  • PurpleAI Selected for South Korea Deep Tech TIPS Program
  • New Webinar Replay: Unboxing AI ft. PurpleAI & CARPL
  • PurpleAI at the Korean Society of Emergency Medicine
  • Co-locating the primary stroke center with the ED was associated with higher thrombolysis rates, a workflow-architecture result with no AI involved
  • What CMS's FY2027 IPPS Rule Actually Changed for Breakthrough Devices and When
  • Synergistic Diagnosis of Acute Ischemic Stroke via Multimodal Attention Fusion of NCCT and FT-Transformer–Based Clinical Metadata
  • Prospective multicenter prehospital LVO screening scale
  • How much can you infer from a plain CT scan?
  • HAGIV ICH Prognostic Score
  • A field's own experts called AI-based tools their most-debated topic in stroke imaging — then said proceed with caution
  • Guideline lowered imaging bar for thrombectomy; affected hospitals are rural
  • ISO/IEC 42001 becoming baseline for clinical AI
  • 66 million Americans in rural counties; stroke disparities
  • Thrombectomy eligibility window widening; imaging is the gatekeeper
  • OCEANIC-STROKE / Asundexian
  • 2026 AHA/ASA Acute Ischemic Stroke Guideline - what every team needs to know
  • 2026 AHA/ASA Acute Ischemic Stroke Guideline — What Every Stroke Team Needs to Know
  • New benchmark for post-stroke outcome prediction
  • 2026 AHA/ASA guidelines create a reimbursement inflection point
  • GOLDEN BRIDGE II - AI that changes what happens after the scan
  • Federal push for imaging interoperability
  • Hematoma Expansion Prediction - 20 years, no clinical standard
  • From detection to prediction in stroke AI
  • CMS finalizes first-ever MIPS measure targeting AI safety
  • Rural stroke care is scaling and getting more advanced
  • FASTEST Trial @ ISC 2026 - precision wake-up call in ICH
  • Pediatric Stroke Imaging - CT is essential
  • Advancing stroke care with AI-integrated remote collaboration
  • 2026 AHA/ASA guidelines officially endorse Mobile Stroke Units
  • Academic Signal Watch - stroke AI moving beyond black box models
  • Prehospital stroke care moving upstream - MSU + AI converging
  • CPT updates a turning point for CT perfusion / neuro-AI
  • Portable MRI meets diagnostic-grade stroke imaging
  • Stroke Care Has a Missing First Mile
  • Whole-Brain AI is the Next Chapter in Stroke Care
  • From Black Box to Bedside Partner: Real-Time, Explainable AI
  • From Detection to Prediction: Reimagining Stroke Care
  • Mobile Stroke Units (MSUs): blueprint for decentralized stroke care
  • Expanding the Stroke Treatment Window: HOPE Trial Findings
  • ACR Draft Guidelines on AI in Radiology
  • The Next Leap in Stroke AI: Predictive, Preventative, Integrated
  • AI in Neuroradiology: From Promise to Standard of Care
  • Radiology Next Chapter: Smarter Workflows Through AI
  • Redefining Neurological Care: Why Proactive Health Needs AI
  • New Study: Why Consistency Matters in AI-Driven Aneurysm Detection
PurpleAI Logo

Stroke AI: Real-Time Detection. Predictive Intelligence.

Korea HQ3rd Floor, 18 Teheran-ro 20-gil
Gangnam-gu, Seoul, Korea 06235
(82) 2-566-2024US Office225 Dyer Street
Providence, RI 02903
(857) 416-4537
purpleai@purple-ai.co
LinkedIn

Solutions

  • Hyper Insight™ – ICH
  • Hyper Insight™ – ICH Plus
  • Hyper Insight™ – Infarct
  • Hyper Insight™ – ASPECTS
  • Hyper Insight™ – CTA Aneurysm
  • Hyper Insight™ – CTA 3D
  • Hyper Insight™ – CTP
  • Hyper Insight™ – DWI Infarct
  • Hyper Insight™ – CTA Infarct (LVO)
  • Hyper Insight™ – MRA Aneurysm
  • StrokeShieldAI™

Company

  • About
  • Leadership
  • Research
  • Partners

Resources

  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Security Policy
FDA 510(k)KOREA MFDSISO 27001ISO 13485GMP
© 2026 Purple AI Inc. All rights reserved.

Product availability and regulatory status vary by country. Certain products are not cleared for clinical use in all jurisdictions.

News, research, and perspectives shaping clinical AI.

Loading…